Last edition
News about
NPPA approves prices of 25 new drugs, opines compulsory regn & standardisation of medical devices
The National Pharmaceutical Pricing Authority (NPPA) has approved retail prices of 25 new drugs under the Drug Price Control Order (DPCO) 2013, in a meeting held in the end of July, 2021. The Authority meeting also opined that compulsory registration and standardisation of the products are required
US FDA clears Abbott's OCT imaging platform powered by new Ultreon Software
Abbott, a global healthcare leader, announced it has received US Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software
Sanofi to acquire clinical-stage mRNA therapeutics company, Translate Bio for US$ 3.2 billion
As part of Sanofi's endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company
Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners have collaborated to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and commercialise Takeda's norovirus vaccine candidate
Ipsen and Exicure have signed an exclusive collaboration agreement to research, develop, and commercialize novel spherical nucleic acids (SNAs) as potential investigational treatments for Huntington's disease and Angelman syndrome
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company and Canadian biotech firm SaNOtize Research & Development Corp. announced an long term strategic partnership to manufacture, market and distribute its breakthrough nitric oxide nasal spray
Pharmexcil seeks list of products requiring SION norms fixation from exporters
The Pharmaceutical Export Promotion Council of India (Pharmexcil) has asked exporters to provide a list of products requiring Standard Input Output Norms (SION) fixation to help them fulfill export obligations in a timely manner
The Department of Pharmaceuticals (DoP) has extended the timeline for submission of applications under the production linked incentive scheme for promotion of domestic manufacturing of critical key starting materials (KSMs) or drug intermediates and active pharmaceutical ingredients (API) and medical devices, till August 31, 2021
NPPA directs manufacturers and importers of five medical devices to submit data every quarter
The National Pharmaceutical Pricing Authority (NPPA) has directed the manufacturers and importers of the five medical devices it has recently imposed a trade margin cap of 70 per cent to submit quarterly stock details within 10 days from the completion of the quarter, till the time the notification is in force
AbbVie, Calico Life extend partnership to discover & develop new therapies
AbbVie and Calico Life Sciences announced an extension of their leading-edge collaboration to discover, develop and bring to market new therapies for patients with age-related diseases, including neurodegeneration and cancer. This is the second extension of the collaboration originally established in 2014
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy